This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Omnicell To Demonstrate Seamless Interoperability With Diverse Technologies At HIMSS 2013

Stocks in this article: OMCL

MOUNTAIN VIEW, Calif., March 4, 2013 /PRNewswire/ --  Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will demonstrate the interoperability of its automated dispensing systems with an array of other medical systems in the HIMSS Interoperability Showcase at the 2013 HIMSS Conference and Exhibition in New Orleans. Omnicell has also been selected to participate in the Intelligent Hospitalâ„¢ Pavilion, which provides a practical overview of how diverse technologies, including medical devices and systems, can interoperate to improve patient care.

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

Omnicell will also showcase its G4 Unity platform at HIMSS booth 8141, including the debut of an enhanced version of its Controlled Substance Management System (CSM), which supports healthcare facilities requiring inventory accountability of medications stored on open shelving within secured vault environments. The CSM system also supports the management of controlled substances in secured dispensing cabinets and refrigerators.

CSM extends medication accountability beyond the loading dock by providing automated, electronic ordering to medication distributors and the Drug Enforcement Administration's Controlled Substance Ordering System (CSOS). The agnostic CSM ordering system gives users the freedom to change distribution vendors and helps to reduce the time spent on the medication ordering process. An independent study showed use of CSM reduced time spent preparing distributor orders by up to 83 percent and reduced time spent preparing CSOS orders for issue by up to 90 percent. 1 

For the third consecutive year, Omnicell will participate in the HIMSS 2013 Interoperability Showcase. Attendees will see a demonstration of the interoperability of Omnicell's automated dispensing systems with an array of other medical systems in an Intensive Care Unit scenario highlighting the coordination of patient care as evidenced by the movement of patient data across the hospital.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.40 +19.24 0.96%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs